1000 related articles for article (PubMed ID: 11897712)
1. Increased islet cell proliferation, decreased apoptosis, and greater vascularization leading to beta-cell hyperplasia in mutant mice lacking insulin.
Duvillié B; Currie C; Chrones T; Bucchini D; Jami J; Joshi RL; Hill DJ
Endocrinology; 2002 Apr; 143(4):1530-7. PubMed ID: 11897712
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia.
Petrik J; Pell JM; Arany E; McDonald TJ; Dean WL; Reik W; Hill DJ
Endocrinology; 1999 May; 140(5):2353-63. PubMed ID: 10218989
[TBL] [Abstract][Full Text] [Related]
3. Increased and persistent circulating insulin-like growth factor II in neonatal transgenic mice suppresses developmental apoptosis in the pancreatic islets.
Hill DJ; Strutt B; Arany E; Zaina S; Coukell S; Graham CF
Endocrinology; 2000 Mar; 141(3):1151-7. PubMed ID: 10698192
[TBL] [Abstract][Full Text] [Related]
4. A low protein diet alters the balance of islet cell replication and apoptosis in the fetal and neonatal rat and is associated with a reduced pancreatic expression of insulin-like growth factor-II.
Petrik J; Reusens B; Arany E; Remacle C; Coelho C; Hoet JJ; Hill DJ
Endocrinology; 1999 Oct; 140(10):4861-73. PubMed ID: 10499546
[TBL] [Abstract][Full Text] [Related]
5. Postnatal development of the endocrine pancreas in mice lacking functional GABAB receptors.
Crivello M; Bonaventura MM; Chamson-Reig A; Arany E; Bettler B; Libertun C; Lux-Lantos V
Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1064-76. PubMed ID: 23531612
[TBL] [Abstract][Full Text] [Related]
6. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
Jetton TL; Liang Y; Cincotta AH
Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
[TBL] [Abstract][Full Text] [Related]
7. Compensatory responses in mice carrying a null mutation for Ins1 or Ins2.
Leroux L; Desbois P; Lamotte L; Duvillié B; Cordonnier N; Jackerott M; Jami J; Bucchini D; Joshi RL
Diabetes; 2001 Feb; 50 Suppl 1():S150-3. PubMed ID: 11272179
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor.
Petrik J; Arany E; McDonald TJ; Hill DJ
Endocrinology; 1998 Jun; 139(6):2994-3004. PubMed ID: 9607811
[TBL] [Abstract][Full Text] [Related]
9. A long-term high-carbohydrate diet causes an altered ontogeny of pancreatic islets of Langerhans in the neonatal rat.
Petrik J; Srinivasan M; Aalinkeel R; Coukell S; Arany E; Patel MS; Hill DJ
Pediatr Res; 2001 Jan; 49(1):84-92. PubMed ID: 11134497
[TBL] [Abstract][Full Text] [Related]
10. Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells.
Hennige AM; Ozcan U; Okada T; Jhala US; Schubert M; White MF; Kulkarni RN
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E337-46. PubMed ID: 15827066
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis.
Christofori G; Naik P; Hanahan D
Mol Endocrinol; 1995 Dec; 9(12):1760-70. PubMed ID: 8614412
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis.
Cooksey RC; Jouihan HA; Ajioka RS; Hazel MW; Jones DL; Kushner JP; McClain DA
Endocrinology; 2004 Nov; 145(11):5305-12. PubMed ID: 15308612
[TBL] [Abstract][Full Text] [Related]
13. Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance.
Freemark M; Avril I; Fleenor D; Driscoll P; Petro A; Opara E; Kendall W; Oden J; Bridges S; Binart N; Breant B; Kelly PA
Endocrinology; 2002 Apr; 143(4):1378-85. PubMed ID: 11897695
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic alterations in insulin-deficient mutant mice.
Duvillié B; Cordonnier N; Deltour L; Dandoy-Dron F; Itier JM; Monthioux E; Jami J; Joshi RL; Bucchini D
Proc Natl Acad Sci U S A; 1997 May; 94(10):5137-40. PubMed ID: 9144203
[TBL] [Abstract][Full Text] [Related]
15. Insulin-Deficient Mouse β-Cells Do Not Fully Mature but Can Be Remedied Through Insulin Replacement by Islet Transplantation.
Ramzy A; Mojibian M; Kieffer TJ
Endocrinology; 2018 Jan; 159(1):83-102. PubMed ID: 29029025
[TBL] [Abstract][Full Text] [Related]
16. Ins1 gene up-regulated in a beta-cell line derived from Ins2 knockout mice.
Leroux L; Durel B; Autier V; Deltour L; Bucchini D; Jami J; Joshi RL
Int J Exp Diabesity Res; 2003; 4(1):7-12. PubMed ID: 12745665
[TBL] [Abstract][Full Text] [Related]
17. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of protein convertase 2 activity results in delayed islet cell differentiation and maturation, increased alpha-cell proliferation, and islet neogenesis.
Vincent M; Guz Y; Rozenberg M; Webb G; Furuta M; Steiner D; Teitelman G
Endocrinology; 2003 Sep; 144(9):4061-9. PubMed ID: 12933680
[TBL] [Abstract][Full Text] [Related]
19. Hyperproliferative state of liver acini and pancreatic islets after intraportal transplantation of a small mass of islets of Langerhans in streptozotocininduced diabetic rats.
Dombrowski F; Pfeifer U
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():112-17. PubMed ID: 8839266
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic capacity of endothelial cells in islets of Langerhans.
Linn T; Schneider K; Hammes HP; Preissner KT; Brandhorst H; Morgenstern E; Kiefer F; Bretzel RG
FASEB J; 2003 May; 17(8):881-3. PubMed ID: 12670881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
